Metsera stock bidding war intensifies as Novo and Pfizer race to secure next-gen obesity drug assets amid surging market ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...

The Danish company’s latest offer is more than 30% about what Pfizer initially agreed to pay, not counting potential ...

Dow Jones Top Company Headlines at 1 PM ET: Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup | Pfizer ... Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup ...

The obesity drug developer has declared a new proposal from Novo “superior” to Pfizer’s original bid as well as an updated ...

Pfizer and Novo Nordisk are engaged in an intense bidding war for obesity drug developer Metsera, with both submitting ...

Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO ...

Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid ...

A Delaware judge said on Tuesday she did not see in a preliminary evaluation the need to involve the court in the bidding war ...

Dow Jones Top Company Headlines at 11 AM ET: Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss Drug Startup Metsera | Pfizer ... Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss ...

The deal comes after Pfizer on Monday filed a second lawsuit against Metsera and Novo Nordisk, alleging the weight-loss drug ...

Novo’s new offer would pay $62.20 per share in cash, revised from the earlier offer of $56.50, according to a Tuesday press ...